These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7020177)

  • 21. Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome.
    Blazar BR; Taylor PA; Snover DC; Sehgal SN; Vallera DA
    J Immunol; 1993 Nov; 151(10):5726-41. PubMed ID: 8228258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of manganese dichloride on the graft vs host activity of splenic lymphocytes in mice].
    Divanian Kh; Boshnakova E
    Eksp Med Morfol; 1988; 27(4):17-9. PubMed ID: 3266148
    [No Abstract]   [Full Text] [Related]  

  • 23. Suppression of xenogeneic local graft versus host reaction by rat fetal spleen cells.
    Skowron-Cendrzak A; Rybczyńska Z; Sajak A; Dobrowolski Z
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):443-6. PubMed ID: 6534317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppressive effects of bovine seminal fluid fractions with ribonuclease activity.
    Soucek J; Hrubá A; Paluska E; Chudomel V; Dostál J; Matousek J
    Folia Biol (Praha); 1983; 29(3):250-61. PubMed ID: 6347732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malononitrilamides inhibit the development of various murine graft-vs-host diseases.
    Schorlemmer HU; Kurrle R; Bartlett RR
    Transplant Proc; 1996 Dec; 28(6):3043-7. PubMed ID: 8962181
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease.
    Ushiyama C; Hirano T; Miyajima H; Okumura K; Ovary Z; Hashimoto H
    J Immunol; 1995 Mar; 154(6):2687-96. PubMed ID: 7876541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H-2 restriction of T cells causing lethal graft-versus-host disease across minor histocompatibility barriers in mice.
    Korngold R; Sprent J
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1217-9. PubMed ID: 7022928
    [No Abstract]   [Full Text] [Related]  

  • 28. Activation of lymphokine mRNA and protein synthesis in vivo in a murine graft-vs-host reaction.
    Kelso A; Troutt AB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):122-4. PubMed ID: 8438247
    [No Abstract]   [Full Text] [Related]  

  • 29. Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity.
    Yamamoto S; Tsuji T; Matsuzaki J; Zhange Y; Chamoto K; Kosaka A; Togashi Y; Sekikawa K; Sawada K; Takeshima T; Koike T; Nishimura T
    Int Immunol; 2004 Jun; 16(6):811-7. PubMed ID: 15126416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of graft-versus-host disease (GVHD) on host hematopoietic progenitor cells is mediated by Fas-Fas ligand interactions but this does not explain the effect of GVHD on donor cells.
    Iwasaki T; Hamano T; Saheki K; Kuroiwa T; Kataoka Y; Takemoto Y; Ogata A; Sugihara A; Terada N; Fujimoto J; Kakishita E
    Cell Immunol; 1999 Oct; 197(1):30-8. PubMed ID: 10555993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemopoietic activity in bone marrow chimeras prepared with total lymphoid irradiation (TLI).
    Slavin S; Seidel HJ
    Exp Hematol; 1982 Feb; 10(2):206-16. PubMed ID: 7037437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possibility of three distinct and separable components to fatal graft-vs-host reaction.
    Okunewick JP; Meredith RF; Raikow RB; Buffo MJ; Jones DL
    Exp Hematol; 1982 Mar; 10(3):277-91. PubMed ID: 7040093
    [No Abstract]   [Full Text] [Related]  

  • 33. The influence of hostsplenectomy on the tumour allograft-promoting effectiveness of antilymphocyte serum.
    Nouza K; Nĕmec M; Dráber P
    Folia Biol (Praha); 1973; 19(4):267-72. PubMed ID: 4148074
    [No Abstract]   [Full Text] [Related]  

  • 34. Direct plaque-forming cell response to sheep red blood cells in rat spleen undergoing graft-versus-host reaction.
    Medzihradský J; Novotná L
    Neoplasma; 1972; 19(1):19-25. PubMed ID: 4401161
    [No Abstract]   [Full Text] [Related]  

  • 35. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of graft versus host reaction by incubation of lymphoid cells with a splenic extract (not affecting the repopulation of the haemopoietic tissue).
    Garcia-Giralt E; Morales VH; Bizzini B; Lasalvia E
    Cell Tissue Kinet; 1973 Nov; 6(6):567-71. PubMed ID: 4148875
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term survival of murine allogeneic bone marrow chimeras: effect of anti-lymphocyte serum and bone marrow dose.
    Norin AJ; Emeson EE; Veith FJ
    J Immunol; 1981 Feb; 126(2):428-32. PubMed ID: 7451985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of graft-versus-host reaction in rats by pretreatment of donor cells with a non-cytotoxic immunosuppressive serum.
    Süsal C; Terness P; Opelz G
    Transplant Proc; 1987 Feb; 19(1 Pt 1):572-5. PubMed ID: 3493563
    [No Abstract]   [Full Text] [Related]  

  • 39. Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier.
    Blazar BR; Taylor PA; Snover DC; Bluestone JA; Vallera DA
    J Immunol; 1993 Jan; 150(1):265-77. PubMed ID: 8417127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new strategy for treatment of malignant tumor: intra-bone marrow-bone marrow transplantation plus CD4- donor lymphocyte infusion.
    Suzuki Y; Adachi Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Ikehara S
    Stem Cells; 2005 Mar; 23(3):365-70. PubMed ID: 15749931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.